相关实验视频
Updated: Jan 16, 2026

10:32
Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
19.0K
治疗耐药精神分裂症的非克洛沙干预措施:系统性审查和元分析
Richard Carr1,2,3, Alistair Cannon4,5, Valeria Finelli4,6
1Department of Psychosis Studies, Institute of Psychiatry, King's College London, London, UK. richard.carr@kcl.ac.uk.
Molecular psychiatry
|October 3, 2025
概括
非克洛扎增强策略在治疗耐药精神分裂症 (TRS) 中表现有前途. 甘氨酸激动剂,非侵入性刺激,心理治疗和抗抑郁药在小型研究中改善了症状,但需要更多的研究来制定常规建议.
科学领域:
- 精神病学和药理学 精神病学和药理学
- 精神分裂症治疗研究研究
背景情况:
- 克洛扎是治疗耐药精神分裂症 (TRS) 的首要治疗方法.
- 当克洛沙平不可行或不能耐受时,需要采取替代干预措施.
- 本综述评估了TRS管理的非克洛沙平选择.
研究的目的:
- 系统地审查和元分析TRS非克洛扎宾干预措施的疗效.
- 评估对精神分裂症的正面,负面和总体症状的影响.
- 为了为TRS患者的临床决策提供信息,不适合克洛沙平.
主要方法:
- 78项研究的系统综述和元分析 (元分析中的68项,3241名患者).
- 在PsycInfo,PubMed和EMBASE数据库中搜索到2023年7月.
- 随机效应模型用于估计效应大小 (Hedges' g);用于质量评估的Cochrane偏差风险工具 (v2).
主要成果:
- 高剂量的抗精神病药物没有改善症状.
- 甘氨酸激动剂改善了积极,消极和总体症状 (低至非常低等级).
- 非侵入性刺激和心理治疗适度改善了积极症状 (低等级).
- 抗抑郁药物增强改善了负面和总症状 (非常低到低等级).
- 对于一些干预措施,发现了小样本大小和出版偏差.
结论:
- 一些非克洛沙平策略,包括药物治疗,非侵入性刺激和心理治疗,在小型研究中显示出好处.
- 目前没有任何干预措施达到作为克洛扎宾替代品的常规推的证据值.
- 高质量的临床试验对于制定TRS管理的最终建议至关重要.
相关概念视频
Psychosis: Goals of Pharmacotherapy
469
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
469
Drug Therapy
242
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
242
Psychosis and Antipsychotic Drugs: Overview
816
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
816
Antipsychotic Drugs: Typical and Atypical Agents
749
Antipsychotic drugs are classified into first-generation (typical) drugs including phenothiazines; and second-generation (atypical) drugs. Chlorpromazine hydrochloride (Thorazine), a phenothiazine derivative, broadly impacts the central, autonomic, and endocrine systems. This drug, along with typical agents like haloperidol (Haldol), primarily works by antagonizing D2 receptors, thus reducing dopaminergic neurotransmission. However, typical antipsychotics can cause side effects such as sedation...
749
Antidepressant Drugs: MAOIs and Other Agents
823
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
823
Psychological and Sociocultural Causes of Schizophrenia
468
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
468

